Terms: = Kidney tumors AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
430 results:
1. Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.
Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
J Cell Mol Med; 2024 May; 28(9):e18329. PubMed ID: 38693863
[TBL] [Abstract] [Full Text] [Related]
2. HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells.
Lv D; Chen Y; Tang L; Tian Y; Ren D; Jian N; Shen T
In Vivo; 2024; 38(3):1094-1103. PubMed ID: 38688591
[TBL] [Abstract] [Full Text] [Related]
3. MMPs-related risk model identification and SAA1 promotes clear cell renal cell carcinoma migration via erk-AP1-MMPs axis.
Wei H; Li Y; Zhang J; Xu C; Wei D; Quan C; Zhu S
Sci Rep; 2024 Apr; 14(1):9411. PubMed ID: 38658579
[TBL] [Abstract] [Full Text] [Related]
4. The vasculogenic mimicry related signature predicts the prognosis and immunotherapy response in renal clear cell carcinoma.
Gu Y; Huang Q; Wang Y; Wang H; Xiang Z; Xu Y; Wang X; Liu W; Wang A
BMC Cancer; 2024 Apr; 24(1):420. PubMed ID: 38580922
[TBL] [Abstract] [Full Text] [Related]
5. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract] [Full Text] [Related]
6. A case of esophageal squamous cell carcinoma accompanied by pancreatic and bile duct metastases: Successful treatment starts with an accurate diagnosis.
Ito Y; Ikura Y; Sawai H; Osuga T
J Cancer Res Ther; 2023 Oct; 19(7):2060-2063. PubMed ID: 38376319
[TBL] [Abstract] [Full Text] [Related]
7. Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating p38/JNK Signaling Pathway.
Lu J; Chen J; Ye J; Shi Z; Gao X; Chen P; Chang Y; Lin H; Li P
Int J Nanomedicine; 2024; 19():1097-1108. PubMed ID: 38327597
[TBL] [Abstract] [Full Text] [Related]
8. Pterostilbene and 6-shogaol exhibit inhibitory effects on sunitinib resistance and motility by suppressing the RLIP76-initiated Ras/erk and Akt/mTOR pathways in renal cancer cells.
Chiang IC; Chen SY; Hsu YH; Shahidi F; Yen GC
Eur J Pharmacol; 2024 Mar; 967():176393. PubMed ID: 38325792
[TBL] [Abstract] [Full Text] [Related]
9. Anti-cancer activity of microbubble conjugated with Sorafenib containing liposome and IL4R-targeting peptide in kidney cancer cells.
Lee J; Park SH
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):266-271. PubMed ID: 38279420
[TBL] [Abstract] [Full Text] [Related]
10. Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity
Ghosh S; Garige M; Haggerty PR; Norris A; Chou CK; Wu WW; Shen RF; Sourbier C
Cell Cycle; 2024 Jan; 23(1):43-55. PubMed ID: 38263737
[TBL] [Abstract] [Full Text] [Related]
11. NSD2 modulates Drp1-mediated mitochondrial fission in chronic renal allograft interstitial fibrosis by methylating STAT1.
Zhang J; Xie W; Ni B; Li Z; Feng D; Zhang Y; Han Q; Zhou H; Gu M; Tan R
Pharmacol Res; 2024 Feb; 200():107051. PubMed ID: 38190956
[TBL] [Abstract] [Full Text] [Related]
12. Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks erk Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.
Wu Y; Chen S; Yang X; Sato K; Lal P; Wang Y; Shinkle AT; Wendl MC; Primeau TM; Zhao Y; Gould A; Sun H; Mudd JL; Hoog J; Mashl RJ; Wyczalkowski MA; Mo CK; Liu R; Herndon JM; Davies SR; Liu D; Ding X; Evrard YA; Welm BE; Lum D; Koh MY; Welm AL; Chuang JH; Moscow JA; Meric-Bernstam F; Govindan R; Li S; Hsieh J; Fields RC; Lim KH; Ma CX; Zhang H; Ding L; Chen F
Cancer Res; 2023 Dec; 83(24):4161-4178. PubMed ID: 38098449
[TBL] [Abstract] [Full Text] [Related]
13. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract] [Full Text] [Related]
14. Baicalein improves the chemoresistance of ovarian cancer through regulation of CirSLC7A6.
Li S; Yi Z; Li M; Zhu Z
J Ovarian Res; 2023 Nov; 16(1):212. PubMed ID: 37940982
[TBL] [Abstract] [Full Text] [Related]
15. The single-cell evolution trajectory presented different hypoxia heterogeneity to reveal the carcinogenesis of genes in clear cell renal cell carcinoma: Based on multiple omics and real experimental verification.
Ma B; Qin L; Sun Z; Wang J; Tran LJ; Zhang J; Ye F; Liu Y; Chen M
Environ Toxicol; 2024 Feb; 39(2):869-881. PubMed ID: 37886854
[TBL] [Abstract] [Full Text] [Related]
16. Corosolic acid inhibits metastatic response of human renal cell carcinoma cells by modulating erk/MMP2 signaling.
Wu TK; Hung TW; Chen YS; Pan YR; Hsieh YH; Tsai JP
Environ Toxicol; 2024 Feb; 39(2):857-868. PubMed ID: 37860891
[TBL] [Abstract] [Full Text] [Related]
17. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
Kim B; Lee S; Moon KC
Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
[TBL] [Abstract] [Full Text] [Related]
18. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
19. Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis.
Morris MT; Jain A; Sun B; Kurbatov V; Muca E; Zeng Z; Jin Y; Roper J; Lu J; Paty PB; Johnson CH; Khan SA
Cancer Lett; 2023 Oct; 574():216384. PubMed ID: 37716465
[TBL] [Abstract] [Full Text] [Related]
20. The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and erk signaling.
Shi J; Miao D; Lv Q; Wang K; Wang Q; Liang H; Yang H; Xiong Z; Zhang X
Cell Death Dis; 2023 Aug; 14(8):560. PubMed ID: 37626050
[TBL] [Abstract] [Full Text] [Related]
[Next]
